Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP505096.RA7Gyw3w24juIci03NMw1y7CwKjnlslO3DaSBVv16zEpI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505096.RA7Gyw3w24juIci03NMw1y7CwKjnlslO3DaSBVv16zEpI130_assertion type Assertion NP505096.RA7Gyw3w24juIci03NMw1y7CwKjnlslO3DaSBVv16zEpI130_head.
- NP505096.RA7Gyw3w24juIci03NMw1y7CwKjnlslO3DaSBVv16zEpI130_assertion description "[In contrast, the CpG island in the FHIT promoter region was hypermethylated in 25 of the 36 (69.4%) analyzed cases of esophageal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505096.RA7Gyw3w24juIci03NMw1y7CwKjnlslO3DaSBVv16zEpI130_provenance.
- NP505096.RA7Gyw3w24juIci03NMw1y7CwKjnlslO3DaSBVv16zEpI130_assertion evidence source_evidence_literature NP505096.RA7Gyw3w24juIci03NMw1y7CwKjnlslO3DaSBVv16zEpI130_provenance.
- NP505096.RA7Gyw3w24juIci03NMw1y7CwKjnlslO3DaSBVv16zEpI130_assertion SIO_000772 12632095 NP505096.RA7Gyw3w24juIci03NMw1y7CwKjnlslO3DaSBVv16zEpI130_provenance.
- NP505096.RA7Gyw3w24juIci03NMw1y7CwKjnlslO3DaSBVv16zEpI130_assertion wasDerivedFrom befree-20140225 NP505096.RA7Gyw3w24juIci03NMw1y7CwKjnlslO3DaSBVv16zEpI130_provenance.
- NP505096.RA7Gyw3w24juIci03NMw1y7CwKjnlslO3DaSBVv16zEpI130_assertion wasGeneratedBy ECO_0000203 NP505096.RA7Gyw3w24juIci03NMw1y7CwKjnlslO3DaSBVv16zEpI130_provenance.